Specifically, expression analysis revealed increased NLRP3 expression in pediatric BCP‐ALL and MLL‐ALL PDX samples compared to the other five leukemia subtypes analyzed, with T‐ALL exhibiting the lowest expression level. This evidence concerns the gene NLRP3 and acute lymphoblastic leukemia.